行情

PAVM

PAVM

PAVmed
NASDAQ

实时行情|Nasdaq Last Sale

1.970
+0.150
+8.25%
交易中 13:31 03/31 EDT
开盘
1.800
昨收
1.820
最高
2.065
最低
1.720
成交量
65.00万
成交额
--
52周最高
3.450
52周最低
0.8100
市值
7,241.92万
市盈率(TTM)
-3.1476
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测PAVM价格均价为3.000,最高价位3.000,最低价为3.000。

EPS

PAVM 新闻

更多
  • 特朗普呼吁推出"大规模且大胆"的2万亿美元基建法案
  • 新浪美股 · 57分钟前
  • 高盛预计美经济二季度萎缩34% 但将出现有史以来最快复苏
  • 新浪美股 · 1小时前
  • 美联储:新冠疫情可能导致4700万人失业,市场会如何反应?
  • 新浪财经综合 · 1小时前
  • 美股翻盘成泡影?8500亿美元驰援资金恐将爽约
  • 新浪财经综合 · 1小时前

所属板块

先进医疗设备和技术
-1.53%
医疗设备和用品
-0.77%

热门股票

代码
价格
涨跌幅

PAVM 简况

PAVmed Inc. is a medical device company organized to conceive, develop and commercialize a diversified pipeline of products. The Company's products include PortIO, Caldus, CarpX, NextCath, DisappEAR and NextFlo. PortIO is an implantable vascular access device, which does not require accessing the central venous system and does not have an indwelling intravascular component. CarpX is a percutaneous device to treat carpal tunnel syndrome. NextCath is a self-anchoring catheter, which does not require suturing, traditional anchoring techniques or add-on catheter securement devices. The Company's DisappEAR is an Antibiotic-eluting Resorbable Ear Tubes. The Company is engaged in developing and commercializing antibiotic-eluting resorbable ear tubes based on an aqueous silk technology conceived and developed at these institutions. The Company is engaged in developing disposable infusion system with variable flow resistors. Caldus is a disposable tissue ablation device.
展开

微牛提供PAVmed Inc(NASDAQ-PAVM)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的PAVM股票新闻,以帮助您做出投资决策。